Market Cap $9 million for this unknown company is a PURE GIFT ..Company is close to Profitability and they expect to release important phase 2 results in November for their Atopic Dermatis trial ,if positive this low float stock likely to explode toward $1 very fast . Market Cap $9 M Price : $0.12 Presentation http://groupedevonian.com/wp-conten...eral-meeting-of-shareholders-mtl-jan-2020.pdf Devonian Health Group announces completion of Enrollment in its Phase 2 Clinical Trial of Thykamine for the Treatment of mild-to-moderate Atopic Dermatitis in adult population. http://groupedevonian.com/devonian-...derate-atopic-dermatitis-in-adult-population/ *Last-patient-last-visit took place on June 3rd, 2020 *Top-line results expected to be reported in November 2020 Devonian Health Group Announces R-Spinasome® anti-aging technology global sales and marketing partnership. http://groupedevonian.com/devonian-...ology-global-sales-and-marketing-partnership/ Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs. http://groupedevonian.com/devonian-...nt-of-cannabinoid-based-pharmaceutical-drugs/
